Evommune EVMN
NYSE EVMN
$7.19 -1.07 (-12.95%)
As of: Oct 1, 2026 · 3:59 PM EDT

Evommune (EVMN) Accumulated Expenses (2024 - 2026)

Updated

Evommune's Accumulated Expenses came in at $10.69 million for Q2 2026, up 125.8% from the prior quarter.

Analysis

Evommune (EVMN) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Accumulated Expenses was $9.55 million, up 41.9% from FY2024.

  • Going back by year, Accumulated Expenses was $6.73 million in FY2024.
  • Business Quant data shows EVMN's Accumulated Expenses at $4.73 million (Q1 2026), $9.55 million (Q4 2025) and $6.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Evommune 299.69 Mn -337.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.69 Mn
Mar 31, 2026 4.73 Mn
Dec 31, 2025 9.55 Mn
Sep 30, 2025 6.31 Mn
Dec 31, 2024 6.73 Mn
API Access

Evommune Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=EVMN&period=max&api_key=YOUR_API_KEY